Research Axis
Fetomaternal and Neonatal Pathologies Axis
Research Theme
Fetal development and prematurity
Address
CHUSJ - Centre de Recherche
Phone
514 345-4931 ext.4268
Our lab explores the role of epigenetic dysregulation in developmental and neurodevelopmental disorders.
Epigenetic modifications are chemical tags added to DNA or the proteins (histones) that compact and organize it. These modifications help regulate gene activity, turning genes on or off during specific stages of development, without altering the underlying DNA sequence. During embryonic development, cells follow complex programs controlled by dynamic changes in these epigenetic marks. Disruptions in this embryonic epigenetic programming can increase vulnerability to developmental and neurodevelopmental disorders.
Serge McGraw's research program investigates how early epigenetic disruptions lead to such disorders, with three main focus areas:
- How inherited epigenetic errors affect early embryonic development.
- How epigenetic errors in brain cells contribute to fetal alcohol spectrum disorder (FASD).
- How mutations in epigenetic genes (e.g., DNMT3A) disrupt brain cell identity and function in overgrowth and neurodevelopmental disorders, such as Tatton-Brown-Rahman Syndrome (TBRS).
Using genetic and environmental models, including mouse embryos, mouse embryonic stem cells, patient-derived induced pluripotent stem cells (iPSCs), neurons, and 3D cortical organoids, as well as multi-omics sequencing and bioinformatic approaches, our work examines both normal and disrupted epigenetic processes to uncover the mechanisms underlying (neuro)developmental disorders in children. We study how early disruptions in brain-related epigenetic programs can alter cell fate, affect cellular development and function, and lead to neurodevelopmental disorders. Our research aims to pave the way for targeted epigenetic therapies to treat these brain disorders
Career Summary
Serge McGraw obtained his PhD at Laval University (Quebec), where he worked with Dr. Marc-André Sirard on the factors involved in chromatin remodeling in gametes and embryos. Subsequently, he joined the group of Dr. Jacquetta Trasler at the Research Institute of the McGill University Health Center at the Montreal Children's Hospital where he developed an expertise in developmental biology and in epigenetics. As a postdoctoral fellow, he investigated epigenetic instability associated with epigenetic disruption during embryonic development. His work highlights the importance of the continuous activity of DNMT1, involved in the maintenance of DNA methylation profiles, in the early embryonic days for the future regulation of genes necessary for the nervous system. Dr. McGraw was recruited in 2015 as a researcher at the CHU Sainte-Justine Research Centre and in the Department of Obstetrics and Gynecology at the Université de Montréal, where he is currently an associate professor.
Laboratory
Developmental Epigenetics and Neurodevelopment Lab